| [1] |
梁慧颖,邹勇.冻干水痘减毒活疫苗发展现状及趋势[J].中国新药杂志,2012,21(10):1076-1161.
|
| [2] |
Sauerbrei A,Zell R,Harder M,et al.Genotyping of different varicella vaccine strains[J].J Clin Virol,2006,37(2):109-117.doi:10.1016/j.jcv.2006.07.002.
|
| [3] |
Takahashi M,Okuno Y,Otsuka T,et al.Development of a live attenuated varicella vaccine[J].Biken J,1975,18(1):25-33.
|
| [4] |
Cohrs RJ,Gilden DH,Gomi Y,et al.Comparison of virus transcription during lytic infection of the oka parental and vaccine strains of varicella-zoster virus[J].J Virol,2006,80(5):2076-2082.doi:10.1128/JVI.80.5.2076-2082.2006.
|
| [5] |
Tillieux SL,Halsey WS,Thomas ES,et al.Complete DNA sequence of two oka strain varicella-zoster virus genomes[J].J Virol,2008,82(22):11023-11044.doi:10.1128/JVI00777-08.
|
| [6] |
Quinlivan ML,Gershon AA,AlBassam MM,et al. Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts[J].PNAS,2007,104(1):208-212.doi:10.1073/pnas. 0605688104.
|
| [7] |
Lau YL,Vessey SJ,Chan IS,et al.A comparison of safety,tolerability and immunogenicity of oka/merck varicella vaccine and VARILRIX in healthy children[J].Vaccine,2002,20(23-24):2942-2949.doi:10.1016/S0264-410X(02)00245-1.
|
| [8] |
LaRussa P,Lungu O,Hardy I,et al. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates[J].J Virol,1992,66(2):1016-1020.
|
| [9] |
LaRussa P,Steinberg S,Arvin A,et al. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world[J].J Infect Dis,1998,178(1):S64-S66.
|
| [10] |
Loparev VN,Argaw T,Krause PR,et al.Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR[J].J Clin Microbiol,2000,38(9):3156-3160.
|
| [11] |
Hondo R,Yogo Y,Yoshida M,et al.Distribution of varicella-zoster virus strains carrying a PstⅠ-site-less mutation in Japan and DNA change responsible for the mutation[J].Jpn J Exp Med,1989,59(6):233-237.
|
| [12] |
Quinlivan ML,Jensen NJ,Radford KW,et al.Novel genetic variation identified at fixed loci in ORF62 of the oka varicella vaccine and in a case of vaccine-associated herpes zoster[J].J Clin Microbiol,2012,50(5):1533-1538.doi:10.1128/JCM.06630-11.
|
| [13] |
Quinlivan M,Gershon AA,Steinberg SP,et al.An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus[J].J Med Virol,2005,75(1):174-180.doi:10.1002/jmv.20253.
|
| [14] |
Yamanishi K.Molecular analysis of the oka vaccine strain of varicella-zoster virus[J].J Infect Dis,2008,197(s2):S45-S48.doi:10.1086/522122.
|
| [15] |
Gomi Y,Ozaki T,Nishimura N,et al.DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the oka varicella vaccine[J].Vaccine,2008,26(44):5627-5632.doi:10.1016/j. vaccine.2008.07.069.
|
| [16] |
Gomi Y,Sunamachi H,Mori Y,et al.Comparison of the complete DNA sequences of the oka varicella vaccine and its parental virus[J].J Virol,2002,76(22):11447-11459.doi:10.1128/JVI.76.22.11447-11459.2002.
|
| [17] |
Kinchington PR,Hougland JK,Arvin AM,et al.The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles[J].J Virol,1992,66(1):359-366.
|
| [18] |
Perera LP,Mosca JD,Ruyechan WT,et al.A major transactivator of varicella-zoster virus,the immediate-early protein IE62,contains a potent N-terminal activation domain[J].J Virol,1993,67(8):4474-4483.
|
| [19] |
Sadzot-Delvaux C,Rentier B.The role of varicella zoster virus immediate-early proteins in latency and their potential use as components of vaccines[J].Arch Virol Suppl,2001,17(17):81-89.doi:10.1007/978-3-7091-6259-0_9.
|
| [20] |
Gomi Y,Imagawa T,Takahashi M,et al.Comparison of DNA sequence and transactivation activity of open reading frame 62 of oka varicella vaccine and its parental viruses[J].Arch Virol Suppl,2001,17(17):49-56.doi:10.1007/978-3-7091-6259-0_6.
|
Acta Academiae Medicinae Sinica
)
